CURRENT CASES
fertility industry
Fertility Industry
Holding a Powerful Industry Accountable
The fertility industry is built on hope, trust, and deeply personal decisions about building a family. Patients rely on doctors, clinics, and genetic testing companies to provide accurate information and responsible care during one of the most vulnerable times in their lives.
But too often, that trust is misplaced.
Justice Law Collaborative represents individuals and families harmed by failures within the fertility industry, including misleading genetic testing, lack of transparency, and practices driven more by profit than patient outcomes. In a multi-billion-dollar industry with limited oversight, critical decisions are sometimes shaped by incomplete, inaccurate, or misleading information.
We are committed to holding fertility clinics, laboratories, and testing companies accountable and to helping bring greater transparency and integrity to this rapidly evolving field.
The Reality Behind Fertility Treatment
Fertility care is complex and expensive. Treatments such as IVF, embryo freezing, and genetic testing often cost tens of thousands of dollars, with many services not covered by insurance.
Patients are frequently offered additional “add-on” services, including genetic testing, that are presented as improving outcomes. In reality, many of these services lack clear scientific support and may be overpromoted without full disclosure of risks or limitations.
At Justice Law Collaborative, we focus on uncovering where the science, the marketing, and the reality diverge, especially when that gap leads to harm.
Updates:
- Luminary Genetics PGT-A Embryo Genetic Testing Class Action Lawsuit Filed in California
- Class action lawsuits against genetic testing companies over PGT-A
- Why is PGT-A Testing Under Scrutiny and Litigation?
- Patients Sue California Firm Saying Discredited Fertility Test Stole Their Chance at Parenthood
Contact us for a free consultation today.
Get In TouchCurrent Cases & Investigations
PGT-A Genetic Testing Litigation
Justice Law Collaborative, alongside co-counsel Berger Montague and Constable Law, has filed multiple class action lawsuits against leading genetic testing companies related to preimplantation genetic testing for aneuploidy (PGT-A).
These cases allege that companies misled patients about the benefits and accuracy of PGT-A testing, which is often marketed as a way to improve IVF success rates and increase the likelihood of a healthy pregnancy.
👉 To learn more about these cases, read the full announcement
Defendants include:
- CooperGenomics, Inc.
- CooperSurgical, Inc.
- The Cooper Companies, Inc.
- Reproductive Genetic Innovations, LLC
- Progenesis, Inc.
- Natera, Inc.
Filed cases span multiple jurisdictions, including New Jersey, Illinois, and California.
Key allegations include:
- False and misleading marketing about success rates and outcomes
- Lack of reliable scientific evidence supporting claims
- Failure to disclose risks and limitations of testing
- Financial harm to patients paying thousands per cycle
These lawsuits seek to recover out-of-pocket costs and damages for patients who relied on inaccurate or incomplete information when making life-altering decisions.
Why PGT-A Is Under Scrutiny
PGT-A is designed to identify embryos with the correct number of chromosomes, helping guide decisions about which embryos to transfer. However, growing evidence and expert concern have raised serious questions about how the test is marketed and used.
Concerns include:
- Questionable accuracy, including false positives and false negatives
- Lack of proven benefit in improving live birth outcomes
- Potential risks from biopsy, freezing, and thawing processes
- Inconsistent results across laboratories
- Overuse in certain patient populations
- Financial incentives driving widespread adoption
At its core, these cases raise a fundamental issue: patients are making deeply personal decisions based on information that may not be accurate, complete, or scientifically supported.
Ovation Fertility / LifeView Investigation
Justice Law Collaborative is also investigating reports involving Ovation Fertility’s LifeView PGT-A platform, where patients may have received faulty or inaccurate test results.
These results may have influenced critical decisions, including whether embryos were deemed viable or discarded.
Reported concerns include:
- Incorrect or unreliable embryo classifications
- Patients and physicians relying on flawed data
- Offers of free services in exchange for agreements not to pursue legal action
If confirmed, these practices raise serious concerns about transparency, accountability, and patient protection within the fertility industry.
Moving Toward Accountability
These cases are about more than financial loss. They are about trust, informed decision-making, and the right to accurate information when building a family.
Justice Law Collaborative is committed to helping clients understand their options, seek accountability, and contribute to meaningful change in an industry that impacts so many lives.